Investegate announcements from Karolinska Development AB (pub, Karolinska Development s portfolio company AnaCardio raises SEK 33 million to progress clinical development of a novel therapy for heart failure
STOCKHOLM, SWEDEN February 3, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed a fundraising of SEK 33 million comprised of a
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND,.
STOCKHOLM, SWEDEN 11 January 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Svenska Vaccinfabriken has appointed Richard Bethell as new CEO. He will
STOCKHOLM, SWEDEN - 11 January 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented results from a preclinical study showing